• 实验研究 • Previous Articles Next Articles
Received:
Revised:
Published:
Online:
Contact:
Abstract: Objective: To explore the inhibitory effect of berbamine on the proliferation of UMR-106 cells and its possible mechanism in vitro. Objective: To explore the inhibitory effect of berbamine on the proliferation of UMR-106 cells and its possible mechanism in vitro. Methods: UMR-106 cells were cultured with different concentrations of berbamine (0,2,4,8,16 and 32 mg/L) for 24, 48 and 72 h ,respectively,and the proliferation were colorimetrically assayed by MTT. UMR-106 cells were interfered with different concentrations of berbamine (0,4,8 and 16 mg/L)for 24h,the morphological changes of UMR-106 cells were observed by laser confoca1 scan microscope after Hoechst33258 staining, the apoptotic rates were detected by flow cytometry (FCM)using Annexin V/PI staining, the cell cycle were detected by FCM using PI staining. Results: Berbamine could obviously inhibit the proliferation of UMR-106 cells in a dose-dependent manner (P < 0.01).The IC50 value at 24,48 and 72h were 24.69、8.03 and 3.54 mg/L, respectively. There were nuclear condensation and apoptotic body in berbamine treated group. Apoptotic rates of control group and berbamine treated group were (1.64±0.29)% ,(3.58±0.31) %,(6.27±0.47) % and (11.27±1.09) %,respectively.There was a significant difference in apoptotic rate compared with the control group (P < 0.01). Meanwhile, berbamine can induce cell necrosis .In addition, berbamine significantly increased the percentages of cells in G0/G1 phase and decreased in S phase and G2/M phase compared with the control group (P <0.01). Conclusion:berbamine can inhibit the proliferation of UMR-106 cells in vitro, inducing cell apoptosis , necrosis and G0/G1 phase arrest may be the mechanism .
Key words: berbamine , osteosarcoma , cell proliferation, apoptosis, cell cycle, in vitro , dose-response relationship, 药物
/ Recommend
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.tjyybjb.ac.cn/EN/
https://www.tjyybjb.ac.cn/EN/Y2012/V/I10/1030